Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Outperform Rating from JMP Securities
Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report)‘s stock had its “market outperform” rating reissued by research analysts at JMP Securities in a report issued on Monday,Benzinga reports. They currently have a $20.00 price objective on the stock. Separately, William Blair reissued a “market perform” rating on shares of Terns Pharmaceuticals in a research report on […]
Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report)‘s stock had its “market outperform” rating reissued by research analysts at JMP Securities in a report issued on Monday,Benzinga reports. They currently have a $20.00 price objective on the stock. Separately, William Blair reissued a “market perform” rating on shares of Terns Pharmaceuticals in a research report on […]
-logo-1200x675.jpg?v=20240830130102&w=240&h=240&zc=2){kind=logo}